Erroneous inflation of diabetes prevalence: Are there global implications?

Journal of Diabetes

Volumn 8, Issue 6, 2016, Pages 766-769

  Taylor, Richard ^a   Zimmet, Paul ^b,c   Naseri, Take ^d   Hufanga, Sione ^e   Tukana, Isimeli ^f   Magliano, Dianna J ^b   Lin, Sophia ^a   Linhart, Christine ^a   Morrell, Stephen ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^c MONASH UNIVERSITY   (Australia)

^d Ministry of Health   (Samoa)

^e Ministry of Health Tonga   (Tonga)

^f Ministry of Health   (Fiji)

Author keywords

blood glucose; diabetes mellitus; measurement; pacific islands; prevalence

Indexed keywords

GLUCOSE;

ADULT; BLOOD EXAMINATION; BLOOD GLUCOSE METER; DIAGNOSTIC PROCEDURE; GLUCOSE BLOOD LEVEL; HEALTH CARE POLICY; HEALTH SURVEY; HUMAN; LETTER; NON INSULIN DEPENDENT DIABETES MELLITUS; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SOCIAL STATUS;

EID: 84990935106     PISSN: 17530393     EISSN: 17530407     Source Type: Journal    
DOI: 10.1111/1753-0407.12447     Document Type: Letter

References (22)

1. World Health Organization (WHO). Fiji Non-communicable Diseases STEPwise Risk Factor (NCD STEPS) Survey 2002. WHO, Suva, 2007.
2. World Health Organization (WHO). 2011 Fiji's NCD Risk Factor Profile 2011 by Gender. WHO, Suva, 2014.
3. World Health Organization (WHO). Samoa NCD Risk Factors STEPS Report 2002. WHO, Apia, 2008.
4. World Health Organization (WHO). Samoa NCD Risk Factors STEPS Report 2014. WHO, Suva, 2014.
5. World Health Organization (WHO). Kingdom of Tonga NCD Risk Factors STEPS Report 2004. WHO, Suva, 2012.
6. World Health Organization (WHO). Kingdom of Tonga NCD Risk Factors STEPS Report 2012. WHO, Suva, 2014.
7. Moodie M, Hope S, Hufanga SV. prepared for the World Health Organization, Western Pacific Region. In: Costs of Implementation of the Package of Essential Non-Communicable Disease (PEN) Interventions in Tonga. Melbourne, Deakin University, 2015.
8. Hoy D, Roth A, Viney K, Souares Y, Lopez AD. Findings and implications of the Global Burden of Disease 2010 Study for the Pacific Islands. Prev Chronic Dis. 2014; 11: 130344.
9. World Health Organization (WHO). Definition, diagnosis and classification of diabetes mellitus and its complications. Report of a WHO consultation. Part 1: Diagnosis and classification of diabetes mellitus. World Health Organization, Geneva, 1999.
10. Roche Diabetes Care Limited. Accu-Chek® test strips have changed to plasma calibration. Available at: https://www.accu-chek.co.uk/gb/news/14april10.html, accessed 21 May 2016.
11. Roche Diagnostics. Accutrend® GCT User's Manual. Roche Diagnostics, Mannheim, 2000.
12. B. Braun Melsungen AG OPM. Omnitest® Plus Blood Glucose Monitoring System user's manual. Available at: http://www.bbraun.com.au/cps/rde/xchg/cw-bbraun-en-au/hs.xsl/products.html?id=00020743280000000066&prid=PRID00003195, accessed 21 May 2016.
13. Roche Diagnostics. Quick! Who needs to be screened for cardiovascular disease? Accutrend Plus: Spot on. On the spot. Roche Diagnostics, Switzerland, 2010. [brochure]. Available at: http://www.cobas.com/content/dam/cobas_com/pdf/product/Accutrend-Plus-system/Accutrend%20Plus%20brochure.pdf, accessed 21 May 2016.
14. Roche Diagnostics GmbH. Accu-Chek® Performa Blood Glucose Meter owner's booklet. Available at: https://www.accu-chek.com.au/wcsstore/RDAUDC/img/files/performa_manual.pdf, accessed 21 May 2016.
15. Burnett RW, D'Orazio P, Fogh-Andersen N et al. IFCC recommendation on reporting results for blood glucose. Clin Chim Acta. 2001; 307: 205–209.
16. D'Orazio P, Burnett RW, Fogh-Andersen N et al. Approved IFCC recommendation on reporting results for blood glucose (abbreviated). Clin Chem. 2005; 51: 1573–1576.
17. Lin S, Tukana I, Linhart C et al. Diabetes and obesity trends in Fiji over 30 years based on empirical data. J Diabetes. 2016; 8: 533–543.
18. Lin S, Naseri T, Linhart C et al. Trends in diabetes and obesity in Samoa over 35 years, 1978–2013. Diabet Med. 2016; in press.
19. Lin S, Hufanga S, Linhart C et al. Diabetes and obesity trends in Tonga over 40 years. Asia Pac J Public Health. 2016; Epub ahead of print. pii:1010539516645156.
20. World Health Organization (WHO). Chronic diseases and health promotion. STEPSwise approach to surveillance (STEPS). Available at: www.who.int/chp/steps, accessed 21 May 2016.
21. World Health Organization (WHO). Vanuatu NCD Risk Factors STEPS Report 2011–12. WHO, Suva, 2013.
22. Davies J, Yudkin JS, Atun R. Liberating data: The crucial weapon in the fight against NCDs. Lancet Diabetes Endocrinol. 2016; 4: 197–198.